Psychedelic Business Spotlight: June 11, 2021

Psychedelic Business Spotlight: June 11, 2021

,
This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.

MORE Companies to UPLIST On NASDAQ? Compass Pathways Trial Results & More (CMPS, FTRP, MYCO, CYBN) 🚀

Compass Pathways (CMPS:NASDAQ) published amazing COMP360 Psilocybin Study results that will serve as support for companies working with psilocybin and psilocybin derivatives. However, this isn't the only news worth mentioning. Field Trip Health (FTRP: CSE) and (FTRPF: OTC) recently uplisted on the TSX ( Toronto Stock Exchange) and has filed an application to uplist on the Nasdaq. While this is great news for Field Trip, it is not the only company who has filed to uplist. Silo Pharma, (SILO: OTC), has also put in an application to list on NASDAQ. MagicMed will also join the ranks, however it will be through an acquisition. Moreover, Cybin (CYBN: NEO,) and (CLXPF: OTC), is working on a transportable, wearable, helmet that completes a brain scan, through a partnership with a company called Kernel. There is also news on Mydecine ( MYCO: NEO) and ( MYCOF: OTC) and MindCure (CSE: MCUR) (OTCQB: MCURF), so stay tuned till the end! Enjoy the episode! Timestamps: 0:00 - Intro 0:51 - Compass Pathways COMP360 Study Results 3:37 - Cybin Ketamine Study 7:14- Field Trip Uplists on the TSX And Applies To List On The NASDAQ 11:10 - Silo Pharma Applies To Uplist on The NASDAQ 12:11 - MagicMed to List On NASDAQ Through Acquisition 15:16- Mydecine Expands Cultivation Capabilities for Psilocybin 17:32- MINDCURE Completes First Stage of Manufacturing Synthetic Ibogaine Links: Compass Pathways Study Results On The Safety And Cognitive Effects Of Taking a Dose Of Psilocybin COMP360: https://www.globenewswire.com/news-release/2021/06/03/2241445/0/en/COMPASS-Pathways-and-Kings-College-London-publish-cognition-results-from-COMP360-psilocybin-study-in-healthy-volunteers.html Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral Cortex Hemodynamics https://psilocybinalpha.com/news/cybin-announces-sponsorship-of-a-kernel-flow-feasibility-study-to-measure-ketamines-psychedelic-effects-on-cerebral-cortex-hemodynamics Field Trip Health Uplists on the TSX: https://www.globenewswire.com/news-release/2021/06/03/2241200/0/en/Field-Trip-Health-Ltd-to-Commence-Trading-on-the-Toronto-Stock-Exchange-on-June-7-2021.html FTRP Applies To Uplist On NASDAQ: https://stockhouse.com/news/the-market-herald-news/2021/06/08/field-trip-health-tsx-ftrp-applies-to-list-on-nasdaq-stock-market MagicMed Will Be Acquired by Nasdaq-listed Enveric Biosciences https://psilocybinalpha.com/news/magicmed-to-be-acquired-by-nasdaq-listed-company Health Canada Has Approved an Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms MYCO: NEO), (MYCOF: OTC) : https://finance.yahoo.com/news/health-canada-approves-expansion-mydecine-113000924.html MINDCURE, (CSE: MCUR) (OTCQB: MCURF), Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research: https://www.prnewswire.com/news-releases/mindcure-successfully-completes-first-stage-of-manufacturing-synthetic-ibogaine-for-use-in-psychedelic-clinical-research-301304810.html Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com editing:@themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #CompassPathways #Mydecine #FieldTrip
Psychedelic Genetic Test Kit

First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.

The first genetic psychedelic test kit is now available in the U.S. The kits are designed to help users know how they'll respond to psychedelics.
Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics

Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics

Seattle city council members are being asked to review decriminalizing psychedelics.
Psilocybin Shows Promise As Treatment for Migraines

Psilocybin Shows Promise As Treatment for Migraines

A new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising prospect.

MindMed’s CEO RESIGNS! What’s NEXT for MMED / MNMD Stock? [ My Thoughts? ]

MindMed Changes CEO? Hey Guys! What a day it has been! Today, MindMed (MMED :NEO), (MNMD: NASDAQ), and (MMQ: FRA) has announced that JR Rahn has stepped down as CEO of MindMed effective immediately. Chief Development Officer, Robert Barrow will assume the role while MindMed is considering possible candidates. In this episode, we’ll cover several things. 1.What happened? 2.My general thoughts on the leadership change. 3.My thoughts on JR Rahn's successes and his departure. 4.What Robert Barrow brings to the table as CEO. Links: MindMed changes leadership: https://mindmed.co/news/press-release/mindmed-announces-chief-executive-officer-transition/ Robert Barrow background: https://mindmed.co/team/robert-barrow-1/ https://www.newswire.ca/news-releases/mindmed-adds-chief-development-officer-with-fda-phase-2-psilocybin-clinical-trial-experience-862550304.html General Reddit sentiment about MindMed's leadership change: https://www.reddit.com/r/MindMedInvestorsClub/comments/nvwtou/expected_this_sub_to_be_on_fire_this_morning_but/ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #MNMD #MindmedNews
Connecticut Governor Signs Psychedelic Reform Deal

Connecticut Governor Signs Psychedelic Reform Deal

Connecticut has become the newest state to consider reform proposals regarding psychedelic medicines.
LSA Is Nature's LSD: Meet the Unsynthesized Psychedelic Found In 1,000 Flowers

LSA Is Nature’s LSD: Meet the Unsynthesized Psychedelic Found In Ancient Flowers

What is LSA? Meet the unsynthesized psychedelic similar to LSD but found abundantly in nature and prized around the world.

MindMed Added To The Russell 3000 and The MSCI Canada Index [Where Does MNMD/MMED Go From Here?]

MindMed (NASDAQ: MNMD), (MMED: NEO) has been added to two major indexes; the Russell 3000 and the Morgan Stanley Capital International Canada Index. In this segment we will explain what that means and how this news will influence the stock price. Links: MindMed (MMED / MNMD) added to the Russell 3000: https://www.reddit.com/r/MindMedInvestorsClub/comments/nsle8l/mnmd_added_to_the_russell_3000_index/ https://www.reddit.com/r/MindMedInvestorsClub/comments/nsqcz5/big_news_mindmed_has_been_added_to_one_of_the/ MindMed added to the MSCI Canada Index: https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/neo-exchange-announces-eligibility-in-msci-indexes Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #MNMD #MindmedNews

Interview With Fruiting Bodies Collective

We chat with Rebecca Martinez and Elan Hagens who are the Founders of Fruiting Bodies Collective.